A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

NCT06883305 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

990

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BIOLOGICAL: Tezepelumab
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]